Evidence map›Paper›PMID 37801221›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2023

Assignment of the antibacterial potential of Ag

Eithar El-Mohsnawy, Abdelhamid El-Shaer, Fadia El-Gharabawy, Eslam E El-Hawary, Abd El-Raheem Ramadan El-Shanshoury

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Aquatic-derived Streptomyces cavourensis BA1 as a promising source of antibacterial metabolites against multidrug-resistant gram-negative pathogens.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Eithar El-MohsnawyMicrobial Biotechnology Unit, Botany and Microbiology Department, Faculty of Science, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt. eithar@sci.kfs.edu.eg.ORCID http://orcid.org/0000-0002-0060-3421
Abdelhamid El-ShaerNanotechnology Unit, Physics Department, Faculty of Science, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt.ORCID https://orcid.org/0000-0002-4204-6053
Fadia El-GharabawyMicrobial Biotechnology Unit, Botany and Microbiology Department, Faculty of Science, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt.
Eslam E El-HawaryPediatric Hematology and Oncology Department, Faculty of Medicine, Tanta University, Tanta, 31527, Egypt.ORCID https://orcid.org/0000-0002-4460-1567
Abd El-Raheem Ramadan El-ShanshouryBacteriology Unit, Microbiology Section, Botany and Microbiology Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt.ORCID https://orcid.org/0000-0001-6642-7574
Kafrelsheikh University · EGTanta University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rate of infectious diseases started to be one of the major mortality agents in the healthcare sector. Exposed to increased bacterial infection by antibiotic-resistant bacteria became one of the complications that occurred for bone marrow transplant patients. Nanotechnology may provide clinicians and patients with the key to overcoming multidrug-resistant bacteria. Therefore, this study was conducted to clarify the prevalence of MDR bacteria in bone marrow transplant recipients and the use of Ag

Indexed as

Proteus mirabilisZinc OxideAnti-Bacterial AgentsBacteriaBone MarrowBone Marrow TransplantationDiarrheaHumansSalmonella typhiAnti-Bacterial AgentsZinc OxideAg2O/ZnO nanocompositeBone marrow transplantMDR bacteriaProteus mirabilis and Salmonella typhi

Identifiers

PMID37801221
PMCPMC10689719
OpenAlexW4387392807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.